Mural Oncology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.34-0.50-0.38-0.41
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-5.29$-3.63$-4.75$-4.45

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.36-0.31-0.47N/A-0.31
Price/Sales ratio
N/AN/AN/AN/AN/A
Price/Book Value ratio
-3.54-2.920.37N/A-2.92
Price/Cash Flow ratio
-0.40-0.37-0.50N/A-0.37
Price/Free Cash Flow ratio
-0.39-0.36-0.49N/A-0.36
Price/Earnings Growth ratio
N/A-0.02-0.12N/A-0.02
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/A
Effective Tax Rate
-0.03%-2.50%-6.22%N/A-2.50%
Return on Assets
-499.66%-592.68%-68.74%N/A-592.68%
Return On Equity
981.22%923.67%-78.63%N/A923.67%
Return on Capital Employed
-9413.04%2498.66%-71.36%N/A2498.66%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
0.120.119.55N/A0.11
Cash ratio
-0.76-0.469.33N/A-0.46
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A
Days of Payables Outstanding
2.62K702.98849.29N/A702.98
Cash Conversion Cycle
N/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.720.570.02N/A0.57
Debt Equity Ratio
-1.41-0.890.02N/A-0.89
Long-term Debt to Capitalization
12.86-1.66N/AN/A-1.66
Total Debt to Capitalization
3.40-8.540.02N/A-8.54
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-6.19-8.69-31.85N/A-8.69
Company Equity Multiplier
-1.96-1.551.14N/A-1.55
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.021.031.01N/A1.03
Cash Flow Coverage Ratio
-6.19-8.69-31.85N/A-8.69
Short Term Coverage Ratio
-26.46-28.84-31.85N/A-28.84
Dividend Payout Ratio
N/AN/AN/AN/AN/A